Jiang FC - Search Results

1

Short-term Pharmacological Inhibition of MyD88 Homodimerization by a Novel Inhibitor Promotes Robust Allograft Tolerance in Mouse Cardiac and Skin Transplantation.

Li C, Zhang LM, Zhang X, Huang X, Liu Y, Li MQ, Xing S, Yang T, Xie L, Jiang FC, Jiang HY, He WT, Zhou P. Li C, et al. Among authors: jiang hy, jiang fc. Transplantation. 2017 Feb;101(2):284-293. doi: 10.1097/TP.0000000000001471. Transplantation. 2017. PMID: 27607533

2

Targeting of MyD88 Homodimerization by Novel Synthetic Inhibitor TJ-M2010-5 in Preventing Colitis-Associated Colorectal Cancer.

Xie L, Jiang FC, Zhang LM, He WT, Liu JH, Li MQ, Zhang X, Xing S, Guo H, Zhou P. Xie L, et al. Among authors: jiang fc. J Natl Cancer Inst. 2015 Dec 28;108(4):djv364. doi: 10.1093/jnci/djv364. Print 2016 Apr. J Natl Cancer Inst. 2015. PMID: 26712311

3

Pharmacological inhibition of MyD88 homodimerization counteracts renal ischemia reperfusion-induced progressive renal injury in vivo and in vitro.

Zhang LM, Liu JH, Xue CB, Li MQ, Xing S, Zhang X, He WT, Jiang FC, Lu X, Zhou P. Zhang LM, et al. Among authors: jiang fc. Sci Rep. 2016 Jun 1;6:26954. doi: 10.1038/srep26954. Sci Rep. 2016. PMID: 27246399 Free PMC article.

4

Beyond knockout: A novel homodimerization-targeting MyD88 inhibitor prevents and cures type 1 diabetes in NOD mice.

Zhang X, Xing S, Li M, Zhang L, Xie L, He W, Liu J, Chang S, Jiang F, Zhou P. Zhang X, et al. Metabolism. 2016 Sep;65(9):1267-77. doi: 10.1016/j.metabol.2016.05.005. Epub 2016 May 14. Metabolism. 2016. PMID: 27506734

5

A novel MyD88 inhibitor attenuates allograft rejection after heterotopic tracheal transplantation in mice.

Yang M, Chen G, Zhang X, Ding Z, Miao Y, Yang Y, Chen ZK, Jiang F, Chang S, Zhou P. Yang M, et al. Transpl Immunol. 2019 Apr;53:1-6. doi: 10.1016/j.trim.2018.11.006. Epub 2018 Nov 22. Transpl Immunol. 2019. PMID: 30472390

6

Modulating the conformation of the TIR domain by a neoteric MyD88 inhibitor leads to the separation of GVHD from GVT.

Xing S, Zhang X, Huang X, Xie L, Jiang F, Zhou P. Xing S, et al. Leuk Lymphoma. 2019 Jun;60(6):1528-1539. doi: 10.1080/10428194.2018.1537487. Epub 2018 Dec 3. Leuk Lymphoma. 2019. PMID: 30501537

7

Short-term use of MyD88 inhibitor TJ-M2010-5 prevents d-galactosamine/lipopolysaccharide-induced acute liver injury in mice.

Ding Z, Du D, Yang Y, Yang M, Miao Y, Zou Z, Zhang X, Li Z, Zhang X, Zhang L, Wang X, Zhao Y, Jiang J, Jiang F, Zhou P. Ding Z, et al. Int Immunopharmacol. 2019 Feb;67:356-365. doi: 10.1016/j.intimp.2018.11.051. Epub 2018 Dec 21. Int Immunopharmacol. 2019. PMID: 30583234

8

Implication of myeloid differentiation factor 88 inhibitor TJ-M2010-5 for therapeutic intervention of hepatocellular carcinoma.

Liu J, Zhang X, Wang H, Zhang M, Peng Y, Li M, Xie L, Jiang F, Gong Y, Zhao Q, Zhou P. Liu J, et al. Hepatol Res. 2019 Oct;49(10):1182-1194. doi: 10.1111/hepr.13359. Epub 2019 May 9. Hepatol Res. 2019. PMID: 31074165

9

TJ-M2010-5, a novel MyD88 inhibitor, corrects R848-induced lupus-like immune disorders of B cells in vitro.

Zou Z, Du D, Miao Y, Yang Y, Xie Y, Li Z, Zhou L, Zhang L, Zhou P, Jiang F. Zou Z, et al. Int Immunopharmacol. 2020 Aug;85:106648. doi: 10.1016/j.intimp.2020.106648. Epub 2020 Jun 5. Int Immunopharmacol. 2020. PMID: 32504998

10

Inhibition of MyD88 by a novel inhibitor reverses two-thirds of the infarct area in myocardial ischemia and reperfusion injury.

Miao Y, Ding Z, Zou Z, Yang Y, Yang M, Zhang X, Li Z, Zhou L, Zhang L, Zhang X, Du D, Jiang F, Zhou P. Miao Y, et al. Am J Transl Res. 2020 Sep 15;12(9):5151-5169. eCollection 2020. Am J Transl Res. 2020. PMID: 33042411 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

60 results

Search Page

Filters